Executives: Outrage Over Pharma Profiteering Is ‘Perversion Of Reality’

The drug makers defended their products as life saving, and dismissed concerns over prices as "more of a campaign issue than an actual issue." In other pharmaceutical news, a California cost transparency bill is shelved and the Pfizer and Allergan CEOs tout plans to boost medicine production.